These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28279422)

  • 1. Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.
    Blaes A; Prizment A; Koene RJ; Konety S
    Heart Fail Clin; 2017 Apr; 13(2):367-380. PubMed ID: 28279422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients.
    Johnson CB; Davis MK; Law A; Sulpher J
    Can J Cardiol; 2016 Jul; 32(7):900-7. PubMed ID: 27343745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer as a Risk Factor for Cardiovascular Disease.
    Giza DE; Iliescu G; Hassan S; Marmagkiolis K; Iliescu C
    Curr Oncol Rep; 2017 Jun; 19(6):39. PubMed ID: 28421481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Markers of endocrine system and inflammation as prognostic risk factors of vascular complications of type 2 diabetes mellitus].
    Verbovoĭ AF; Morkovskikh NV
    Vestn Ross Akad Med Nauk; 2011; (3):37-42. PubMed ID: 21542374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering Innovative Drugs Targeting Both Cancer and Cardiovascular Disease by Shared Protein-Protein Interaction Network Analyses.
    Tiwari S; Dwivedi UN
    OMICS; 2019 Sep; 23(9):417-425. PubMed ID: 31329050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preface to special issue on: Adiposopathy in Cancer and (Cardio)Metabolic Diseases: an Endocrine Approach - Part 4.
    Chetrite GS; Fève B
    Horm Mol Biol Clin Investig; 2015 Jul; 23(1):1-4. PubMed ID: 26353175
    [No Abstract]   [Full Text] [Related]  

  • 9. Obesity and cardiovascular disease.
    Jokinen E
    Minerva Pediatr; 2015 Feb; 67(1):25-32. PubMed ID: 25387321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibrosis marker galectin-3 and outcome in the general population.
    de Boer RA; van Veldhuisen DJ; Gansevoort RT; Muller Kobold AC; van Gilst WH; Hillege HL; Bakker SJ; van der Harst P
    J Intern Med; 2012 Jul; 272(1):55-64. PubMed ID: 22026577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of adiponectin and leptin to coronary artery disease, classical cardiovascular risk factors and atherothrombotic biomarkers in the IARS cohort.
    Shanker J; Rao VS; Ravindran V; Dhanalakshmi B; Hebbagodi S; Kakkar VV
    Thromb Haemost; 2012 Oct; 108(4):769-80. PubMed ID: 22955445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of maternal gestational diabetes on the cardiovascular risk factor profile of infants at 1 year of age.
    Retnakaran R; Ye C; Hanley A; Sermer M; Connelly P; Zinman B; Hamilton J
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1175-81. PubMed ID: 23786820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Regular Exercise on Inflammatory and Cardiovascular Risk Markers in Normal Weight, Overweight and Obese Adults.
    Gondim OS; de Camargo VT; Gutierrez FA; Martins PF; Passos ME; Momesso CM; Santos VC; Gorjão R; Pithon-Curi TC; Cury-Boaventura MF
    PLoS One; 2015; 10(10):e0140596. PubMed ID: 26474157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic factors and risk of cardiovascular disease in women. An overview.
    Meilahn EN
    Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age diseases depending on geomagnetic field activity inside the womb period].
    Iamshanov VA
    Adv Gerontol; 2010; 23(4):554-6. PubMed ID: 21510078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the "adipokine paradox": When the classic proatherogenic adipokine leptin is deemed the beneficial one.
    Antonopoulos AS; Antoniades C; Tousoulis D
    Int J Cardiol; 2015 Oct; 197():125-7. PubMed ID: 26126055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.
    Liu J; Young TK; Zinman B; Harris SB; Connelly PW; Hanley AJ
    Obesity (Silver Spring); 2006 Mar; 14(3):500-8. PubMed ID: 16648622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.
    Scialla JJ
    Curr Opin Nephrol Hypertens; 2015 May; 24(3):260-7. PubMed ID: 26066475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.
    Martin SS; Qasim A; Reilly MP
    J Am Coll Cardiol; 2008 Oct; 52(15):1201-10. PubMed ID: 18926322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?
    Rial NS; Choi K; Nguyen T; Snyder B; Slepian MJ
    Med Hypotheses; 2012 Jan; 78(1):29-32. PubMed ID: 22014759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.